← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2007Last known activity
Jan 1, 2009
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
- Central Nervous System Neoplasms
- Dermatitis
- Dermatitis, Atopic
- Disease
- Eczema
- Leukemia
- Lymphoma
- Lymphoproliferative Disorders
- Multiple Myeloma
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasms
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Preleukemia
- Syndrome
Recent trials (2)
- NCT00823524CollaboratorPhase 1/Phase 2Jan 1, 2009
- NCT00893230CollaboratorPhase 3Jan 1, 2007
Details
- Last known activity
- Jan 1, 2009